Literature DB >> 9655715

Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis.

M J Maliarik1, K M Chen, M L Major, R G Sheffer, J Popovich, B A Rybicki, M C Iannuzzi.   

Abstract

Several studies have found weak associations between certain human leukocyte antigen (HLA) alleles and sarcoidosis, but none have been conclusive. Glutamic acid at position 69 in HLA-DPB1 has been reported to be strongly associated with chronic beryllium disease. The immunopathologic and clinical similarities between chronic beryllium disease (CBD) and sarcoidosis suggest that similar immune-response genes may be involved in susceptibility in both diseases. We analyzed the DNA sequence of HLA-DPB1 exon 2, which contains the hypervariable regions involved in binding antigens, in blood samples from African-American sarcoidosis patients and healthy controls. Results indicate that Val36 (odds ratio [OR] = 2.30) and Asp55 (OR = 2.03) are associated with increased risk for sarcoidosis, but no association with Glu69 was found. These results suggest that although HLA-DPB1 Glu69 is not associated with sarcoidosis, other alleles may make some contribution to susceptibility to sarcoidosis in African-Americans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655715     DOI: 10.1164/ajrccm.158.1.9708111

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 2.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 3.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

4.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

5.  Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.

Authors:  Annegret Fischer; David Ellinghaus; Marcel Nutsua; Sylvia Hofmann; Courtney G Montgomery; Michael C Iannuzzi; Benjamin A Rybicki; Martin Petrek; Frantisek Mrazek; Stefan Pabst; Christian Grohé; Johan Grunewald; Marcus Ronninger; Anders Eklund; Leonid Padyukov; Violeta Mihailovic-Vucinic; Dragana Jovanovic; Martina Sterclova; Jiri Homolka; Markus M Nöthen; Stefan Herms; Christian Gieger; Konstantin Strauch; Juliane Winkelmann; Bernhard O Boehm; Stephan Brand; Carsten Büning; Manfred Schürmann; Eva Ellinghaus; Hansjörg Baurecht; Wolfgang Lieb; Almut Nebel; Joachim Müller-Quernheim; Andre Franke; Stefan Schreiber
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 6.  Genetic polymorphisms in lung disease: bandwagon or breakthrough?

Authors:  Michael C Iannuzzi; Mary Maliarik; Benjamin Rybicki
Journal:  Respir Res       Date:  2002-02-19

Review 7.  Surfactant gene polymorphisms and interstitial lung diseases.

Authors:  Panagiotis Pantelidis; Srihari Veeraraghavan; Roland M du Bois
Journal:  Respir Res       Date:  2001-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.